Portapharma.uk Ltd - Period Ending 2019-12-31
Portapharma.uk Ltd - Period Ending 2019-12-31
Registration number:
Portapharma.uk Ltd
for the Period from 1 November 2018 to 31 December 2019
Portapharma.uk Ltd
Contents
|
Company Information |
|
|
Balance Sheet |
|
|
Notes to the Financial Statements |
Portapharma.uk Ltd
Company Information
|
Directors |
S J Hadcroft R G Kay |
|
Registered office |
|
|
Accountants |
|
Portapharma.uk Ltd
(Registration number: 10409912)
Balance Sheet as at 31 December 2019
|
2019 |
2018 |
|
|
Fixed assets |
|
- |
|
Current assets |
|
|
|
Creditors: Amounts falling due within one year |
( |
- |
|
Net current (liabilities)/assets |
( |
|
|
Total assets less current liabilities |
|
|
|
Provisions for liabilities |
( |
- |
|
Accruals and deferred income |
( |
- |
|
|
|
|
|
Capital and reserves |
|
|
Portapharma.uk Ltd
(Registration number: 10409912)
Balance Sheet as at 31 December 2019
|
General information |
The company is a private company limited by share capital, incorporated in England.
The address of its registered office is:
These financial statements were authorised for issue by the
Basis of preparation
The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.
These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
For the financial period ending 31 December 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
|
• |
|
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
Approved and authorised by the
.........................................
Director